Index by author
Neuner, Elizabeth
- You have accessVancomycin: A 50-something-yearold antibiotic we still don’t understandAmy Schilling, PharmD, Elizabeth Neuner, PharmD and Susan J. Rehm, MDCleveland Clinic Journal of Medicine July 2011, 78 (7) 465-471; DOI: https://doi.org/10.3949/ccjm.78a.10168
To use vancomycin appropriately, we need to recognize its changing minimum inhibitory concentrations, select proper doses and dosing intervals, and know how to monitor its use.
Oommen, Santosh Samuel
- You have accessHypothermia after cardiac arrest: Beneficial, but slow to be adoptedSantosh Samuel Oommen, MD and Venu Menon, MDCleveland Clinic Journal of Medicine July 2011, 78 (7) 441-448; DOI: https://doi.org/10.3949/ccjm.78a.10157
Survivors of cardiac arrest due to ventricular tachycardia or ventricular fi brillation have better neurologic outcomes if they are cooled to a core body temperature of 32°C to 34°C for 24 hours as soon as possible after reaching the hospital.
Rehm, Susan J.
- You have accessVancomycin: A 50-something-yearold antibiotic we still don’t understandAmy Schilling, PharmD, Elizabeth Neuner, PharmD and Susan J. Rehm, MDCleveland Clinic Journal of Medicine July 2011, 78 (7) 465-471; DOI: https://doi.org/10.3949/ccjm.78a.10168
To use vancomycin appropriately, we need to recognize its changing minimum inhibitory concentrations, select proper doses and dosing intervals, and know how to monitor its use.
Schilling, Amy
- You have accessVancomycin: A 50-something-yearold antibiotic we still don’t understandAmy Schilling, PharmD, Elizabeth Neuner, PharmD and Susan J. Rehm, MDCleveland Clinic Journal of Medicine July 2011, 78 (7) 465-471; DOI: https://doi.org/10.3949/ccjm.78a.10168
To use vancomycin appropriately, we need to recognize its changing minimum inhibitory concentrations, select proper doses and dosing intervals, and know how to monitor its use.
Tang, Derek M.
- You have accessRash from hepatitis C treatmentDerek M. Tang, MD and Lawrence Ward, MD, MPHCleveland Clinic Journal of Medicine July 2011, 78 (7) 472-474; DOI: https://doi.org/10.3949/ccjm.78a.10124
Although the combination of interferon and ribavirin is the standard of treatment for chronic hepatitis C, some patients experience adverse reactions.
Ward, Lawrence
- You have accessRash from hepatitis C treatmentDerek M. Tang, MD and Lawrence Ward, MD, MPHCleveland Clinic Journal of Medicine July 2011, 78 (7) 472-474; DOI: https://doi.org/10.3949/ccjm.78a.10124
Although the combination of interferon and ribavirin is the standard of treatment for chronic hepatitis C, some patients experience adverse reactions.